NCT00230139View on ClinicalTrials.gov

SPECT/CT in Endocrine and Neuroendocrine Tumors

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

January 31, 2004

Study Completion Date

January 31, 2006

Conditions
Endocrine and Neuroendocrine Tumors
Interventions
DEVICE

SPECT/CT

Trial Locations (1)

Unknown

Rambam Medical Center, Haifa

All Listed Sponsors
lead

Rambam Health Care Campus

OTHER

NCT00230139 - SPECT/CT in Endocrine and Neuroendocrine Tumors | Biotech Hunter | Biotech Hunter